Results 1 to 10 of about 34,753 (116)

Sutureless versus transcatheter valves in patients with aortic stenosis at intermediate risk: A multi-institutional European study [PDF]

, 2023
Background: Recent randomized controlled trials showed comparable short-term outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in intermediate and low-risk patients.
Baudo, Massimo, D'Alonzo, Michele, Di Bacco, Lorenzo, Di Eusanio, Marco, Fischlein, Theodor, Folliguet, Thierry, Muneretto, Claudio, Pollari, Francesco, Rosati, Fabrizio, Solinas, Marco   +9 more
core   +1 more source

All-cause procedural readmissions following transcatheter aortic valve replacement [PDF]

, 2023
OBJECTIVE: With expanding eligibility criteria, transcatheter aortic valve replacement is being performed on patients with longer life expectancy, and subsequent procedures after index transcatheter aortic valve replacement are inevitable.
Cherkasky, Olena, Harloff, Morgan, Hirji, Sameer, Javadikasgari, Hoda, Kaneko, Tsuyoshi, Malarczyk, Alexandra, McGurk, Siobhan, Newell, Paige, Rojas-Alexandre, Mehida, Sabe, Ashraf, Shah, Pinak   +10 more
core   +2 more sources

Transcatheter heart valve selection and permanent pacemaker implantation in patients with pre-existent right bundle branch block [PDF]

, 2017
Background-Right bundle branch block is an established predictor for new conduction disturbances and need for a permanent pacemaker (PPM) after transcatheter aortic valve replacement.
Abawi, M. (Masieh), Carrié, D. (Didier), de Nicolas, J.M. (Javier Molina-Martin), Dumonteil, N. (Nicolas), Gils, L. (Lennart) van, Jaegere, P.P.T. (Peter) de, Lhermusier, T. (Thibault), Mieghem, N.M. (Nicolas) van, Olivares, R.R. (Ramón Rodriguez), Stella, P.R. (Pieter), Tchetche, D. (Didier)   +10 more
core   +6 more sources

Mixed Valvular Disease Following Transcatheter Aortic Valve Replacement: Quantification and Systematic Differentiation Using Clinical Measurements and Image-Based Patient‐Specific In Silico Modeling [PDF]

, 2020
Background: Mixed valvular disease (MVD), mitral regurgitation (MR) from pre‐existing disease in conjunction with paravalvular leak (PVL) following transcatheter aortic valve replacement (TAVR), is one of the most important stimuli for left ventricle (LV)
Amrute, Junedh M., Ben-Assa, Eyal, Blanke, Philipp, Brown, Jonathan, de la Torre Hernandez, Jose M., Edelman, Elazer R., Garcia Camarero, Tamara, Keshavarz-Motamed, Zahra, Khodaei, Seyedvahid, Lee, Suk Joon, Leipsic, Jonathon, Rikhtegar Nezami, Farhad, Ruano Calvo, Javier, Sellers, Stephanie   +13 more
core   +1 more source

A comprehensive review of the PARTNER trial [PDF]

, 2013
ObjectivePercutaneous transcatheter aortic valve replacement was introduced in 2002, but its effectiveness remained to be assessed.MethodsA prospective, randomized trial (the Placement of Aortic Transcatheter Valves, or PARTNER) was designed with 2 arms:
Blackstone, Eugene H., Gillinov, A. Marc, Kapadia, Samir, Lytle, Bruce W., Roselli, Eric E., Sabik, Joseph F., Svensson, Lars G., Tuzcu, Murat   +7 more
core   +1 more source

Intermediate-Term Risk of Stroke Following Cardiac Procedures in a Nationally Representative Data Set. [PDF]

, 2017
BACKGROUND: Studies on stroke risk following cardiac procedures addressed only perioperative and long-term risk following limited higher-risk procedures, were poorly generalizable, and often failed to stratify by stroke type. We calculated stroke risk in
Dhamoon, Amit S., Dhamoon, Mandip S., Liang, John W., Stein, Laura, Thaler, Alison, Tuhrim, Stanley   +5 more
core   +2 more sources

Transcatheter Aortic Valve Replacement (TAVR) [PDF]

, 2023
Transcatheter aortic valve replacement (TAVR) is becoming the gold standard when repairing aortic stenosis compared to surgical aortic valve replacement (SAVR). Transcatheter aortic valve replacement is minimally invasive.
Bergener, Jocelyn
core   +1 more source

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Baglin A, Braun J, Bryg RJ, Christian Kupatt, Cribier A, Edwards FH, Gerhard Steinbeck, Herzog CA, Iung B, Leon MB, London GM, Lucke JC, Maher ER, Matthias Wessely, Michael Fischereder, Philipp Lange, Rodes-Cabau J, Simon Rau, Smith CR, Stinebaugh J, Straumann E, Tanaka K, Ulf Schönermarck, Urena P, Varadarajan P, Varma R   +25 more
core   +1 more source

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. [PDF]

, 2014
OBJECTIVE: To use patient-level data from the ADVANCE study to evaluate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared to medical management (MM) in patients with severe aortic stenosis from the perspective of the UK ...
Bleiziffer, S, Bosmans, J, Brecker, S, Busca, R, Eaton, J, Gerckens, UJ, Linke, A, Mealing, S, Moat, N, Padhiar, A, Piazza, N, Sculpher, M, Tamburino, C, Wenaweser, P   +13 more
core   +1 more source

Transcatheter aortic valve replacement for acute aortic regurgitation due to Staphylococcus aureus infective endocarditis complicated with a perivalvular abscess: a case report [PDF]

, 2023
Aortic valve endocarditis; Infective endocarditis; Perivalvular abscessEndocarditis de la válvula aórtica; Endocarditis infecciosa; Absceso perivalvularEndocarditis de la vàlvula aòrtica; Endocarditis infecciosa; Abscés perivalvularBackground Infective ...
Fernández-Hidalgo, Nuria, Oristrell, Gerard, Rello, Pau, Universitat Autònoma de Barcelona, Vila-Olives, Rosa   +4 more
core   +2 more sources